oral glp 1 weight loss Lilly orforglipron GLP-1 phase 3 trial Oral GLP-1 Troche — Needle-Free

This means patients often arrive with brand preferences, asking specifically for Ozempic or Wegovy rather than simply a diabetes drug. The intersection of consumer demand, telehealth convenience, and product visibility creates fertile ground for GLP-1 Drug Marketing innovation

Some people lose more than 100 pounds in the first year, particularly those who started at higher weights and responded well to the medication

The Federal Register notice for this proposal was published in early May 2026

Tirzepatide, a dual GIP/GLP-1 receptor agonist, is effective and safe when added to basal insulin for treatment of type 2 diabetes (SURPASS-5)

While the cost can be high, many insurance plans cover these medications

D., Higgins, D